Latest Draft Of Rep. Dingell’s Global Drug Safety Bill Would Exempt Small Firms From Inspection Fees
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA would have flexibility to set inspection schedules; committee may use bill to address FDA executive bonuses